MORLACCO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 3.651
EU - Europa 328
AS - Asia 182
AF - Africa 2
Totale 4.163
Nazione #
US - Stati Uniti d'America 3.649
IT - Italia 162
CN - Cina 151
FI - Finlandia 39
GB - Regno Unito 33
DE - Germania 23
SE - Svezia 22
IE - Irlanda 12
IN - India 12
VN - Vietnam 12
FR - Francia 10
NL - Olanda 5
BE - Belgio 3
BG - Bulgaria 3
ID - Indonesia 3
JP - Giappone 3
PL - Polonia 3
UA - Ucraina 3
CA - Canada 2
GR - Grecia 2
LT - Lituania 2
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
NO - Norvegia 1
RO - Romania 1
Totale 4.163
Città #
Fairfield 851
Woodbridge 377
Ashburn 353
Houston 321
Cambridge 297
Seattle 290
Wilmington 206
Chandler 184
Ann Arbor 128
San Diego 100
Padova 71
Medford 62
Princeton 62
Beijing 45
Des Moines 44
Helsinki 34
Ogden 21
Roxbury 19
Jinan 15
Nanjing 15
Dong Ket 12
Dublin 12
Noventa 12
Boardman 11
London 11
Guangzhou 9
New York 9
Pune 8
Shenyang 8
Milan 7
Bonn 6
Changsha 6
Prescot 6
Bologna 5
Nanchang 5
Ningbo 5
Borås 4
Hebei 4
Paris 4
Rockville 4
Solesino 4
Taiyuan 4
Tianjin 4
Brussels 3
Frankfurt am Main 3
Hangzhou 3
Kharkiv 3
Kilburn 3
Phoenix 3
Redwood City 3
Shanghai 3
Sofia 3
Trieste 3
Venice 3
Abano Terme 2
Ames 2
Aradeo 2
Bay Springs 2
Brendola 2
Camponogara 2
Chicago 2
Dianbu 2
Fontaniva 2
Haikou 2
Hounslow 2
Jakarta 2
Jiaxing 2
Lappeenranta 2
Legnaro 2
Markopoulo Mesogaias 2
Montechiarugolo 2
Norwalk 2
Osaka 2
Palermo 2
Palmanova 2
Pinzolo 2
Poznan 2
Rome 2
Saint-Fons 2
San Martino di Lupari 2
Stockholm 2
Washington 2
Acton 1
Amsterdam 1
Atlanta 1
Boulder 1
Budapest 1
Cairo 1
Castello Di Godego 1
Cavarzere 1
Chiswick 1
Council Bluffs 1
Dallas 1
De Lier 1
Delhi 1
Dueville 1
Edinburgh 1
Esslingen am Neckar 1
Falls Church 1
Fuzhou 1
Totale 3.762
Nome #
Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance 136
The Role of Lymph Node Dissection in the Treatment of Bladder Cancer 133
Adverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active Surveillance 123
Syphilis or cancer? A urological challenge 123
Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence 112
Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy 111
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy 103
High-risk prostate cancer: The role of surgical management 101
Early salvage radiation therapy post-prostatectomy: Key considerations 100
Does 1.5 T mpMRI play a definite role in detection of clinically significant prostate cancer? Findings from a prospective study comparing blind 24-core saturation and targeted biopsies with a novel data remodeling model 95
The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy 93
Duplication of inferior vena cava with obstructed right ureter: An extremely rare anomaly 87
An unusual cystic presentation of ductal carcinoma of the prostate 83
The impact of COVID-19 pandemic on urological emergencies: a single-center experience 83
Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis 80
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study 79
Edges-On-Dartos: An Easy Way to Improve Graft Performance in Staged Hypospadias Repair 79
Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy 74
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil 72
Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series [Figure presented] 72
Prostate biopsy after abdominoperineal resection: a diagnostic challenge 72
Genomic tests to guide prostate cancer management following diagnosis 71
Development of a Surgical Safety Training Program and Checklist for Conversion during Robotic Partial Nephrectomies 70
The New Prostate Cancer Grading System in High-risk Disease: A Big Step Forward? 70
Frailty and elderly in urology: Is there an impact on post-operative complications? 69
Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse 69
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches 69
Arterial Fistula With Severe Hematuria After Ileal Conduit Diversion 66
Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance 66
Prostate cancer: more effective use of underutilized postoperative radiation therapy 66
Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? 65
Re: Maurice et al: Nonclinical factors predict selection of initial observation for renal cell Carcinoma (Urology 2015;86:892-900) 65
Urological Care and COVID-19: Looking Forward 62
Surgical strategies for lymphocele prevention in minimally-invasive radical prostatectomy and lymph-node dissection: a systematic review 61
Effect of Level of Urology Training on Gleason Score and Prostate Volume Estimation Agreement between Transrectal Ultrasound Guided Biopsy and Radical Prostatectomy Specimen 61
Spontaneous prostatic hematoma: an unusual presentation of prostatic cancer 60
MP53-14 MULTIMODAL TREATMENT FOR HIGH-RISK PROSTATE CANCER WITH HIGH-DOSE INTENSITY-MODULATED RADIATION THERAPY, CONCURRENT INTENSIFIED-DOSE DOCETAXEL AND LONG-TERM ANDROGEN DEPRIVATION THERAPY AFTER RADICAL PROSTATECTOMY AND LYMPHADENECTOMY: RESULTS OF A PROSPECTIVE PHASE II TRIAL 58
A retrospective multicentric analysis on testicular torsion: is there still something to learn? 57
Risk-prediction tools in prostate cancer: The challenge of tailoring 56
Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence 56
Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients 54
Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer 54
The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends 54
Open versus robotic-assisted partial nephrectomy: A multicenter comparison study of perioperative results and complications 53
Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review 53
Impact of metabolic syndrome on functional outcomes and complications of surgical treatment of prostate cancer 52
Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure? 51
The multifaceted long-term effects of the COVID-19 pandemic on urology 50
Robot-assisted simple prostatectomy 48
Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer 47
Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy 45
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer 42
Successful Treatment of Vesicovaginal Fistulas via an Abdominal Transvesical Approach: A Single-center 50-yr Experience 38
Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis 37
Metabolic syndrome and stone disease 37
Porcine Small Intestinal Submucosa (SIS) as a Suitable Scaffold for the Creation of a Tissue-Engineered Urinary Conduit: Decellularization, Biomechanical and Biocompatibility Characterization Using New Approaches 35
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 32
Metabolic syndrome and prostate cancer treatment 32
Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies? 20
Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsy 19
A Novel Hybrid Membrane for Urinary Conduit Substitutes Based on Small Intestinal Submucosa Coupled with Two Synthetic Polymers 18
Preliminary In Vitro Assessment of Decellularized Porcine Descending Aorta for Clinical Purposes 18
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional study 17
Bladder Substitution: The Role of Tissue Engineering and Biomaterials 15
Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer 15
Hybrid Materials for Tissue Repair and Replacement: Another Frontier in Biomaterial Exploitation Focusing on Cardiovascular and Urological Fields 13
Diagnosis of clinically significant prostate cancer after negative multiparametric magnetic resonance imaging 13
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer 12
Metabolic syndrome and andrological diseases 12
Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction 8
Transitional care in urology: the road to independence 8
Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy 8
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis 7
Robotic partial nephrectomy for complex kidney cyst in a 4-year old boy: Points of technique 6
Nadir creatinine as a predictor of renal outcomes in PUVs: A systematic review and meta-analysis 6
Cryopreservation effects on biological tissues: histological and mechanical assessments 5
Robotic ureteral reimplantation: systematic review and pooled analysis of comparative outcomes in adults 4
Nomograms in Urologic Oncology: Lights and Shadows 4
Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program 2
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study 1
Perioperative and Functional Results for Robot-assisted Radical Cystectomy with Totally Intracorporeal Neobladder in Male Patients via the Vesica Patavina (Ves.Pa.) Technique: IDEAL Stage 2a Report 1
RISK OF ADVERSE RADICAL PROSTATECTOMY OUTCOMES IN PATIENTS DIAGNOSED WITH IUSP <= 2 PROSTATE CANCER ON MRI/TRUS FUSION BIOPSY 1
Totale 4.275
Categoria #
all - tutte 18.235
article - articoli 17.967
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 195
Totale 36.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019220 0 0 0 0 0 0 0 0 0 44 86 90
2019/20201.037 59 46 12 70 123 52 72 94 202 145 85 77
2020/20211.039 63 93 66 159 33 15 77 111 110 169 97 46
2021/2022966 76 142 73 79 46 87 82 68 31 57 66 159
2022/2023542 124 15 2 35 91 66 15 53 74 5 53 9
2023/2024352 20 52 48 38 31 47 32 21 35 28 0 0
Totale 4.275